Williams; William V.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Williams; William V..The latest application filed is for "sustained-release dosage forms of ruxolitinib".
- Williams; William V. - Havertown PA
| Patent | Date |
|---|---|
| Sustained-release Dosage Forms Of Ruxolitinib App 20220211631 - Ni; Yong ; et al. | 2022-07-07 |
| Sustained-release dosage forms of ruxolitinib Grant 11,337,927 - Ni , et al. May 24, 2 | 2022-05-24 |
| Sustained-release Dosage Forms Of Ruxolitinib App 20210128477 - Ni; Yong ; et al. | 2021-05-06 |
| Sustained-release dosage forms of ruxolitinib Grant 10,874,616 - Ni , et al. December 29, 2 | 2020-12-29 |
| Janus Kinase Inhibitors For Treatment Of Dry Eye And Other Eye Related Diseases App 20200093825 - Friedman; Paul A. ; et al. | 2020-03-26 |
| Sustained-release Dosage Forms Of Ruxolitinib App 20190231696 - Ni; Yong ; et al. | 2019-08-01 |
| Sustained-release dosage forms of ruxolitinib Grant 10,166,191 - Ni , et al. J | 2019-01-01 |
| Janus Kinase Inhibitors For Treatment Of Dry Eye And Other Eye Related Diseases App 20170087158 - Friedman; Paul A. ; et al. | 2017-03-30 |
| Sustained-release Dosage Forms Of Ruxolitinib App 20140135350 - Ni; Yong ; et al. | 2014-05-15 |
| Janus Kinase Inhibitors For Treatment Of Dry Eye And Other Eye Related Diseases App 20120301464 - Friedman; Paul A. ; et al. | 2012-11-29 |
| Compositions and methods for delivery of genetic material Grant 8,304,234 - Weiner , et al. November 6, 2 | 2012-11-06 |
| Janus Kinase Inhibitors For Treatment Of Dry Eye And Other Eye Related Diseases App 20100113416 - Friedman; Paul A. ; et al. | 2010-05-06 |
| Compositions and methods for delivery of genetic material App 20060222629 - Weiner; David B. ; et al. | 2006-10-05 |
| Compositions and methods for delivery of genetic material Grant 7,001,759 - Weiner , et al. February 21, 2 | 2006-02-21 |
| Biologically active compounds and methods of constructing and using the same App 20030144479 - Greene, Mark I. ; et al. | 2003-07-31 |
| Genetic immunization Grant 6,468,982 - Weiner , et al. October 22, 2 | 2002-10-22 |
| Nucleotide sequences encoding vpr receptor protein Grant 6,087,486 - Weiner , et al. July 11, 2 | 2000-07-11 |
| Compositions and methods for delivery of genetic material Grant 5,981,505 - Weiner , et al. November 9, 1 | 1999-11-09 |
| Methods and compositions comprising single chain recombinant antibodies Grant 5,840,300 - Williams , et al. November 24, 1 | 1998-11-24 |
| Methods of identifying biologically active receptor-binding peptides Grant 5,837,460 - Von Feldt , et al. November 17, 1 | 1998-11-17 |
| Genetic immunization Grant 5,830,876 - Weiner , et al. November 3, 1 | 1998-11-03 |
| Genetic immunization Grant 5,817,637 - Weiner , et al. October 6, 1 | 1998-10-06 |
| Biologically active compounds and methods of constructing and using the same Grant 5,637,677 - Greene , et al. June 10, 1 | 1997-06-10 |
| Genetic immunization Grant 5,593,972 - Weiner , et al. January 14, 1 | 1997-01-14 |
| Method of stimulating myelination of cells Grant 5,574,009 - Cohen , et al. November 12, 1 | 1996-11-12 |
| Peptides derived from human immunodeficiency virus-1 GP160 Grant 5,338,829 - Weiner , et al. August 16, 1 | 1994-08-16 |
| Method of stimulating myelination of cells Grant 5,219,837 - Cohen , et al. June 15, 1 | 1993-06-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 